Nasdaq · CIK 0001870144
CDIO Cardio Diagnostics Holdings, Inc.
Insider trading from SEC Form 4. Last filing 11 d ago.
Cardio Diagnostics Holdings, Inc. (CDIO) has 26 SEC Form 4 filings on file from 4 insiders, the latest filed on Oct 2, 2026. No insider bought or sold on the open market in the last 90 days; rows filed in that time are grants, exercises, tax withholding and other transactions that carry no view on the price.
Last 90 days
Signals
Open-market buys and sells at Cardio Diagnostics Holdings, Inc., scored.
Transactions
Every row filed, 26 in all.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | Paul Frederick Burton director | AGrant or award Stock Options (Right to Buy)derivative | +3,286 | $1.90 | $6,243 | 16,607 | 11 d ago |
| Sep 30, 2026 | James Intrater director | AGrant or award Stock Options (Right to Buy)derivative | +3,286 | $1.90 | $6,243 | 16,607 | 11 d ago |
| Sep 30, 2026 | Peter K Fung director | AGrant or award Stock Options (Right to Buy)derivative | +3,286 | $1.90 | $6,243 | 15,656 | 11 d ago |
| Sep 30, 2026 | Wendy J Betts director | AGrant or award Stock Options (Right to Buy)derivative | +3,286 | $1.90 | $6,243 | 15,656 | 11 d ago |
| Mar 31, 2026 | Wendy J Betts director | AGrant or award Stock Options (Right to Buy)derivative | +3,205 | $1.95 | $6,250 | 9,513 | Apr 2, 2026 |
| Mar 31, 2026 | Paul Frederick Burton director | AGrant or award Stock Options (Right to Buy)derivative | +3,205 | $1.95 | $6,250 | 10,464 | Apr 2, 2026 |
| Mar 31, 2026 | James Intrater director | AGrant or award Stock Options (Right to Buy)derivative | +3,205 | $1.95 | $6,250 | 10,464 | Apr 2, 2026 |
| Mar 31, 2026 | Peter K Fung director | AGrant or award Stock Options (Right to Buy)derivative | +3,205 | $1.95 | $6,250 | 9,513 | Apr 2, 2026 |
| Dec 31, 2025 | Wendy J Betts director | AGrant or award Stock Options (Right to Buy)derivative | +2,306 | $2.71 | $6,249 | 6,308 | Jan 6, 2026 |
| Dec 31, 2025 | Paul Frederick Burton director | AGrant or award Stock Options (Right to Buy)derivative | +2,306 | $2.71 | $6,249 | 7,259 | Jan 6, 2026 |
| Dec 31, 2025 | James Intrater director | AGrant or award Stock Options (Right to Buy)derivative | +2,306 | $2.71 | $6,249 | 7,259 | Jan 6, 2026 |
| Dec 31, 2025 | Peter K Fung director | AGrant or award Stock Options (Right to Buy)derivative | +2,306 | $2.71 | $6,249 | 6,308 | Jan 6, 2026 |
| Sep 30, 2025 | Paul Frederick Burton director | AGrant or award Stock Options (Right to Buy)derivative | +1,559 | $4.01 | $6,252 | 4,953 | Oct 3, 2025 |
| Sep 30, 2025 | Peter K Fung director | AGrant or award Stock Options (Right to Buy)derivative | +1,559 | $4.01 | $6,252 | 4,002 | Oct 3, 2025 |
| Sep 30, 2025 | James Intrater director | AGrant or award Stock Options (Right to Buy)derivative | +1,559 | $4.01 | $6,252 | 4,953 | Oct 3, 2025 |
| Sep 30, 2025 | Wendy J Betts director | AGrant or award Stock Options (Right to Buy)derivative | +1,559 | $4.01 | $6,252 | 4,002 | Oct 3, 2025 |
| Jun 30, 2025 | Wendy J Betts director | AGrant or award Stock Options (Right to Buy)derivative | +1,736 | $3.60 | $6,250 | 2,443 | Jul 2, 2025 |
| Jun 30, 2025 | Paul Frederick Burton director | AGrant or award Stock Options (Right to Buy)derivative | +1,736 | $3.60 | $6,250 | 3,394 | Jul 2, 2025 |
| Jun 30, 2025 | James Intrater director | AGrant or award Stock Options (Right to Buy)derivative | +1,736 | $3.60 | $6,250 | 3,394 | Jul 2, 2025 |
| Jun 30, 2025 | Peter K Fung director | AGrant or award Stock Options (Right to Buy)derivative | +1,736 | $3.60 | $6,250 | 2,443 | Jul 2, 2025 |
| Mar 31, 2025 | Wendy J Betts director | AGrant or award Stock Options (Right to Buy)derivative | +18,939 | $0.33 | $6,250 | 21,211 | Apr 1, 2025 |
| Mar 31, 2025 | Paul Frederick Burton director | AGrant or award Stock Options (Right to Buy)derivative | +18,939 | $0.33 | $6,250 | 49,744 | Apr 1, 2025 |
| Mar 31, 2025 | James Intrater director | AGrant or award Stock Options (Right to Buy)derivative | +18,939 | $0.33 | $6,250 | 49,744 | Apr 1, 2025 |
| Mar 31, 2025 | Peter K Fung director | AGrant or award Stock Options (Right to Buy)derivative | +18,939 | $0.33 | $6,250 | 21,211 | Apr 1, 2025 |
| Dec 31, 2024 | Paul Frederick Burton director | AGrant or award Stock Options (Right to Buy)derivative | +4,544 | $0.92 | $4,180 | 30,805 | Jan 15, 2025 |
| Dec 31, 2024 | James Intrater director | AGrant or award Stock Options (Right to Buy)derivative | +4,544 | $0.92 | $4,180 | 30,805 | Jan 15, 2025 |
Insiders
Everyone who has filed a Form 4 here.
- Wendy J Bettsdirector
- Paul Frederick Burtondirector
- Peter K Fungdirector
- James Intraterdirector
Questions about CDIO
Answered from the filings on this page, as of the latest one.
Are insiders buying CDIO?
No. In the last 90 days no insider at Cardio Diagnostics Holdings, Inc. bought or sold shares on the open market according to SEC Form 4 filings. The rows on file from that period are grants, exercises, tax withholding or other transactions, which carry no view on the price.
Who was the last insider to trade CDIO on the open market?
No open-market trade has been scored at Cardio Diagnostics Holdings, Inc.. The latest Form 4 on file was filed on Oct 2, 2026 and holds grants, exercises or other rows that are not market trades.
How many insiders file Form 4 at Cardio Diagnostics Holdings, Inc.?
4 people have filed a Form 4 at Cardio Diagnostics Holdings, Inc., among them Wendy J Betts (director), Paul Frederick Burton (director), Peter K Fung (director). Officers, directors and holders of more than 10% of a share class must report their trades within two business days.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.